Biotech, Indications Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech, Indications

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (8)	7/9/1999 2:49:00 AM
From: sim1	of 22

Alzheimer's... From EBEWE Pharmaceuticals Ltd (An Austrian Co.) ebewe.co.at Have no idea if there is any value here. "...We at EBEWE recognised the importance of pivotal research at an early stage and started future-oriented studies. Our proud result: Cerebrolysin®. Cerebrolysin® is the new innovative standard for the treatment of Alzheimer's disease and stroke - because of Cerebrolysin®'s unique neurotrophic mechanism of action. After Cerebrolysin® treatment, stroke patients experience improved neurorehabilitation and the amount of care needed by Alzheimer's disease sufferers decreases significantly." (snip)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next